Park, Y. H., Ku, J. H., Kwak, C., & Kim, H. H. (2014). Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapy. Springer International Publishing.
Citação norma ChicagoPark, Yong Hyun, Ja Hyeon Ku, Cheol Kwak, and Hyeon Hoe Kim. Post-treatment Neutrophil-to-lymphocyte Ratio in Predicting Prognosis in Patients With Metastatic Clear Cell Renal Cell Carcinoma Receiving Sunitinib As First Line Therapy. Springer International Publishing, 2014.
Citação norma MLAPark, Yong Hyun, Ja Hyeon Ku, Cheol Kwak, and Hyeon Hoe Kim. Post-treatment Neutrophil-to-lymphocyte Ratio in Predicting Prognosis in Patients With Metastatic Clear Cell Renal Cell Carcinoma Receiving Sunitinib As First Line Therapy. Springer International Publishing, 2014.